Business
ASX rises 0.9pc, buoyed by Victoria easing, vaccine development – The Australian Financial Review
The Australian sharemarket closed at a seven-month high on Monday as Victoria eased lockdown restrictions and on news of progress towards a COVID-19 vaccine.
“The crisis support has been significant and the tapering of such will present a drag. That said, the fiscal pivot is meaningful in size and focus. This combined with liquid and willing, monetary support allows for some calibration of an earnings recovery and more normalcy in the cycle.”
CSL led the market gains and a broadly firmer health sector with the British National Health Service deputy chief medical officer Jonathan Van-Tam suggesting the Oxford University vaccine being manufactured by …
-
Noosa News19 hours agoGippsland farmer blocks AusNet maintenance workers from entering property
-
Noosa News23 hours agoProperty stock drops as selling season hits
-
Noosa News20 hours agoNo live export ships coming for WA sheep amid high prices, looming ban
-
Business24 hours agoWith more US rate cuts projected, are fund managers buying or selling US stocks?